Literatur
-
1
Abrahamsson T R, Jakobsson T, Bottcher M F, Fredrikson M, Jenmalm M C, Bjorksten B, Oldaeus G.
Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial.
J Allergy Clin Immunol.
2007;
119
1174-1180
-
2
Brouwer M L, Wolt-Plompen S A, Dubois A E, van der Heide S, Jansen D F, Hoijer M A, Kauffman H F, Duiverman E J.
No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial.
Clin Exp Allergy.
2006;
36
899-906
-
3
Floch M H, Madsen K K, Jenkins D J, Guandalini S, Katz J A, Onderdonk A, Walker W A, Fedorak R N, Camilleri M.
Recommendations for probiotic use.
J Clin Gastroenterol.
2006;
40
275-278
-
4
Gruber C, Wendt M, Sulser C, Lau S, Kulig M, Wahn U, Werfel T, Niggemann B.
Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy.
Allergy.
2007;
62
1270-1276
-
5
Helin T, Haahtela S, Haahtela T.
No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study.
Allergy.
2002;
57
243-246
-
6
Huang J S, Bousvaros A, Lee J W, Diaz A, Davidson E J.
Efficacy of probiotic use in acute diarrhea in children: a meta-analysis.
Dig Dis Sci.
2002;
47
2625-2634
-
7
Huys G, Vancanneyt M, D’Haene K, Vankerckhoven V, Goossens H, Swings J.
Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use.
Res Microbiol.
2006;
157
803-810
-
8
Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E.
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.
Lancet.
2001;
357
1076-1079
-
9
Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E.
Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.
Lancet.
2003;
361
1869-1871
-
10 Kopp M, Hennemuth I, Dietschek A, Goldstein M, Ihorst G, Heinzmann A, Urbanek R. A randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical or immunological effects of Lactobacillus GG supplementation. Pediatrics in press
-
11
Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, Kamm M A, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J.
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
Gut.
2004;
53
1617-1623
-
12
McFarland L V.
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
Am J Gastroenterol.
2006;
101
812-822
-
13
McFarland L V.
Meta-analysis of probiotics for the prevention of traveler’s diarrhea.
Travel Med Infect Dis.
2007;
5
97-105
-
14
Salminen M K, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, Sarna S, Valtonen V, Jarvinen A.
Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland.
Clin Infect Dis.
2002;
35
1155-1160
-
15
Taylor A L, Dunstan J A, Prescott S L.
Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial.
J Allergy Clin Immunol.
2007;
119
184-191
-
16
Van Niel C W, Feudtner C, Garrison M M, Christakis D A.
Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis.
Pediatrics.
2002;
109
678-684
-
17
Wang M F, Lin H C, Wang Y Y, Hsu C H.
Treatment of perennial allergic rhinitis with lactic acid bacteria.
Pediatr Allergy Immunol.
2004;
15
152-158
-
18
Weizman Z, Asli G, Alsheikh A.
Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents.
Pediatrics.
2005;
115
5-9
Prof. Dr. med. Johannes Huebner
Infektiologie, Innere Medizin II, Universitätsklinikum Freiburg
Hugstetter Str. 55
79106 Freiburg
Phone: 0761/270-1828
Fax: 0761/270-1820
Email: johannes.huebner@uniklinik-freiburg.de
